Earlier diagnosis of peripheral neuropathy in primary care: A call to action

Author:

Gad Hoda1,Kalra Sanjay2,Pinzon Rizaldy3,Gracia Rey‐an Nino4,Yotsombut Kitiyot5,Coetzee Ankia6,Nafach Jalal7,Lim Lee‐Ling8,Fletcher Pablo E.9,Lim Vivien10,Malik Rayaz A.111ORCID

Affiliation:

1. Research Department Weill Cornell Medicine‐Qatar Doha Qatar

2. Department of Endocrinology Bharti Hospital Karnal India

3. Neurology Department of the Bethesda General Hospital Yogyakarta Yogyakarta Indonesia

4. College of Medicine, De LA Salle, Health Medical and Science Institute College of Medicine Manila Philippines

5. Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok Thailand

6. Faculty of Medicine and Health Sciences Stellenbosch University Cape Town South Africa

7. Dubai Diabetes Center, Dubai Academic Health Corporation Dubai UAE

8. Department of Medicine, Diabetes Care Unit University of Malaya Kuala Lumpur Malaysia

9. Endocrinology Department, Medical School University of Panama Panama Panama

10. Endocrinology Department Gleneagles Hospital Singapore Singapore

11. Institute of Cardiovascular Medicine University of Manchester Manchester UK

Abstract

AbstractPeripheral neuropathy (PN) often remains undiagnosed (~80%). Earlier diagnosis of PN may reduce morbidity and enable earlier risk factor reduction to limit disease progression. Diabetic peripheral neuropathy (DPN) is the most common PN and the 10 g monofilament is endorsed as an inexpensive and easily performed test for DPN. However, it only detects patients with advanced neuropathy at high risk of foot ulceration. There are many validated questionnaires to diagnose PN, but they can be time‐consuming and have complex scoring systems. Primary care physicians (PCPs) have busy clinics and lack access to a readily available screening method to diagnose PN. They would prefer a short, simple, and accurate tool to screen for PN. Involving the patient in the screening process would not only reduce the time a physician requires to make a diagnosis but would also empower the patient. Following an expert meeting of diabetologists and neurologists from the Middle East, South East Asia and Latin America, a consensus was formulated to help improve the diagnosis of PN in primary care using a simple tool for patients to screen themselves for PN followed by a consultation with the physician to confirm the diagnosis.

Funder

Procter and Gamble

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3